MYC
| 3 min read
Researchers discovered that where mRNA translation occurs in the cytoplasm changes protein expression level and sometimes even function.
| 3 min read
A herpes virus peptide binds and sequesters proteins important for MYC activation in lymphoma cells, presenting a new viral strategy for treating undruggable MYC-dependent cancers.
Page 1 of 1 - 2 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Overcoming barriers in gene therapy
Advanced gene editing, delivery, and analytical tools are driving better gene therapies.
A multiomic approach to profiling brain tumors
Probing the molecular drivers of brain metastasis reveals novel therapeutic targets.
Enhancing immune cell profiling with digital technologies
Software innovations help researchers decode immune complexity in cancer.
